To include your compound in the COVID-19 Resource Center, submit it here.
A U.S. Phase II trial in 19 evaluable patients with newly diagnosed anaplastic astrocytoma showed that
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury